Angiogenic response induced by mechanical transmyocardial revascularization  by Chu, Victor et al.
the mechanism of TMR is still controversial, a growing
amount of clinical and experimental evidence suggests
that TMR-induced angiogenesis plays an important role
in this therapeutic approach.
Clinical development of TMR and its subsequent
governmental approval has benefited immensely from
close collaborations and financial support from the laser
industry. In return, all clinical studies of TMR have
used purposely designed laser devices since the early
1980s. However, the initially proposed advantage of
laser, that is, improved long-term channel patency, is no
longer supported by more recently available data. In
fact, most investigators now believe that TMR achieves
its therapeutic benefits independently of long-term
channel patency.
Alternatively, it has been proposed that TMR induces
T ransmyocardial revascularization (TMR) is a newlydeveloped surgical treatment for patients with
symptomatic end-stage coronary artery diseases who
have exhausted other treatment alternatives. Although
Background: Angiogenesis is the proposed mechanism of transmyocar-
dial revascularization. We evaluated mechanical transmyocardial revas-
cularization in a chronically ischemic porcine model by measuring
myocardial angiogenic response. Methods: Ameroid constrictors were
implanted 6 weeks before mechanical transmyocardial revasculariza-
tion. Group I (n = 5) and group II (n = 3) animals received 30 punctures
with an 18-gauge needle and samples were harvested at 1 and 4 weeks,
respectively, after the operation. Group III (n = 5) had sternotomy only
and served as the control group. Myocardial samples were immunohis-
tochemically stained for vascular endothelial growth factor (VEGF),
basic fibroblast growth factor (bFGF), and transforming growth factor
b (TGF-b ) using specific antibodies. Growth factor expression was
quantified by means of computer-assisted morphometry. Vascular den-
sity was assessed by immunohistochemical stain for VEGF and factor
VIII. Results: Compared with group III, increased angiogenic factor lev-
els were found in group I (VEGF 0.47 ± 0.03 mm2 vs 0.05 ± 0.05 mm2, P
= .000; bFGF 0.67 ± 0.14 mm2 vs 0.03 ± 0.03 mm2, P = .000; TGF-b 1.40
± 0.18 mm2 vs 0.09 ± 0.06 mm2, P = 0.000), and in group II (VEGF 0.34
± 0.06 mm2 vs 0.05 ± 0.05 mm2, P = .003; bFGF 0.06 ± 0.02 mm2 vs 0.03
± 0.03 mm2, P = .135; TGF-b 0.28 ± 0.09 mm2 vs 0.09 ± 0.06 mm2, P =
.042). Vascular densities after mechanical transmyocardial revascular-
ization were also increased (group I, VEGF stain 8.1 ± 0.6 vs 1.1 ± 0.5, P
= .000; factor VIII stain 5.1 ± 2.7 vs 0.4 ± 0.3, P = .018; group II, VEGF
stain 1.9 ± 0.5 vs 1.1 ± 0.5, P = 0.107; factor VIII stain 2.3 ± 0.4 vs 0.4 ±
0.3, P = .004). Conclusions: Mechanical transmyocardial revasculariza-
tion is associated with increased angiogenic factor expression and con-
comitant neovascularization at up to 4 weeks. These changes are indis-
tinguishable from those of laser transmyocardial revascularization.
Myocardial perfusion studies are needed to establish the functional sig-
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ANGIOGENIC RESPONSE INDUCED BY MECHANICAL TRANSMYOCARDIAL REVASCULARIZATION 
angiogenesis and increases myocardial collateral circu-
lation through a tissue injury/wound healing process. A
logical extension of such a hypothesis is that angiogen-
esis is a nonspecific response to tissue injury, which can
be created in a variety of ways. Indeed, in addition to a
wide array of laser sources, radio frequency and simple
needle punctures1 have also been shown to induce
myocardial angiogenesis in animal models.
Mechanical needle puncture deserves further consid-
eration, not only for its simplicity. It has also been
shown by Sen and coworkers2 to be effective in the
treatment of acute myocardial ischemia. More recently,
Whittaker, Rakusan, and Kloner3 demonstrated that
needle punctures were more effective than laser chan-
nels in protecting acute ischemia in an animal model.
Our earlier study4 also indicated that needle TMR com-
pared favorably with a carbon dioxide laser. Neverthe-
less, the effectiveness of needle TMR in promoting
myocardial angiogenesis and its potential as a simple
and low-cost alternative to laser procedures have never
been evaluated.
We performed needle mechanical TMR in a chroni-
cally ischemic porcine model. The purpose of this
study is to further characterize the angiogenic response
following needle TMR, providing a more detailed
analysis with multiple growth factors over different
time points.
Methods
All experimental animals were cared for in accordance
with institutional guidelines and the “Guide for the Care and
Use of Laboratory Animals” prepared by the Institute of
Laboratory Animal Resources, National Research Council,
and published by the National Academy Press, revised 1996.
Animal model with chronic ischemia. Fifteen Yorkshire
pigs weighing 15 to 20 kg were premedicated with intramus-
cular ketamine (15 mg/kg) and were anesthetized with intra-
venous injection of thiopental sodium (15 mg/kg). After oral
endotracheal intubation, anesthesia was maintained with
0.5% to 2.0% isoflurane in room air. Oxygen saturation was
continuously monitored with a transcutaneous oximeter
probe. Cefazolin, 500 mg, was given intravenously before the
skin incision.
Animals were placed in the right lateral decubitus position.
The thoracic area was prepared and draped in a sterile fash-
ion. Exposure of the proximal left circumflex artery was
achieved via a minithoracotomy through the 4th intercostal
space. A 1-cm segment of the left circumflex artery before the
first obtuse marginal branch was dissected free with both
sharp and blunt dissections. Care was taken to minimize
direct manipulation of the artery itself to avoid vessel spasm.
An ameroid constrictor (2.75 mm, Research Instruments and
Manufacturing, Corvallis, Ore) was placed around the left cir-
cumflex artery. The pericardium and the chest were closed in
layers and the anesthesia reversed. The animals were kept for
6 weeks to allow time for gradual occlusion of the left cir-
cumflex artery by ameroid constrictors.
TMR. Six weeks after insertion of the ameroid constrictors,
animals were randomly assigned to 3 groups (n = 5 each).
Groups I and II received 30 needle punctures whereas group
III underwent sternotomy only. Tissue samples from groups I
and III were harvested 1 week after the operation and samples
from group II were harvested 4 weeks after TMR.
All TMR operations were performed through a median
sternotomy. Anesthesia and intubation were performed in the
same fashion as the first operation. All animals received a
prophylactic intravenous lidocaine bolus (2 mg/kg) and were
maintained on a lidocaine infusion (1 mg/min) throughout the
operation. Median sternotomies were performed and the
hearts were exposed by opening the pericardium and careful-
ly dissecting away pericardial adhesions. Needle punctures
were performed in an area measuring approximately 2 · 2 cm
between the 1st and 2nd obtuse marginal arteries with 18-
gauge hypodermic needles. Transmural penetration was con-
firmed by noting pulsatile flow of arterial blood through the
needle. Bleeding was controlled with finger pressure or 4-0
Prolene sutures (Ethicon, Inc, Somerville, NJ), which also
served as markers of puncture sites at the time of tissue har-
vest. Sternums were then closed with steel wires and the inci-
sions closed in layers. Anesthesia was reversed and the ani-
mal allowed to recover.
Sample harvest and cryopreservation. At the time of tis-
sue harvesting, repeat sternotomies were performed through
the same incision. Hearts were isolated by careful dissection
of adhesions. Animals were put to death with an overdose of
pentobarbital and potassium chloride. The ascending aortas
were crossclamped and the hearts fixed in situ by injecting 1
L of ice cold 4% paraformaldehyde through the aortic root.
Full-thickness slices of myocardium from the TMR-treated
area (or corresponding ischemic area in the control group)
were removed and immediately immersed in 4%
paraformaldehyde in phosphate-buffered saline solution.
These were kept at 4°C for 12 hours. The specimens were
then transferred into 15% sucrose in phosphate-buffered
saline solution and kept at 4°C for 3 days. Afterward, samples
were embedded in OCT compound (Tissue-Tek, Sakura
Finetek Inc, Torrance, Calif), snap frozen with liquid nitro-
gen, and kept at –80°C.
All ameroid constrictors were retrieved from the heart and
inspected to confirm vessel occlusion.
Sample analysis
Immunohistochemistry. Cryostat sections of tissue samples
were mounted on glass slides and immunostained with anti-
sera to vascular endothelial growth factor (VEGF), basic
fibroblast growth factor (bFGF), transforming growth factor
b (TGF-b ) (Santa Cruz Biotechnology Inc, Santa Cruz,
Calif), or factor VIII ligands (Sigma-Aldrich Canada Ltd,
Oakville, Ontario, Canada) with a modified avidin biotin-per-
oxidase method.5 Tissue sections were made permeable with
octylphenoxypolyethoxyethanol (Triton X-100; Union
Carbide Corporation, Danbury, Conn), incubated in hydrogen
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peroxide to block endogenous peroxidase activity. They were
then incubated first with normal goat serum for 30 minutes
and followed with the primary antibody for 16 hours at 4°C.
Afterward, they were incubated with biotinylated immuno-
globulin G and stained with an immmunoperoxidase tech-
nique according to the manufacturer’s instructions (Vectastain
ABC Elite Kit; Vector Laboratories, Burlingame, Calif).
Angiogenic growth factor expression. Growth factor
expression was quantified by measuring the area of tissue
sections positively stained for VEGF, bFGF, or TGF-b in
each high-power field (400· ). Measurements were performed
around TMR puncture sites, which were identified by the fol-
lowing criteria: (1) identifiable needle or laser puncture scar
under low-power view (100· ), (2) presence of inflammatory
cells and granulation tissue, and (3) loss of normal myocyte
appearance and homogeneity. With the use of the sampling
method of “systematic sampling with a random start,”6 8
sampling sites from each tissue section were photographed
with a still video camera and digitized into tagged image file
format (TIFF) files. Quantitative measurements of stained
area were performed with an IBM compatible personal com-
puter using Matrox Inspector 2.1 (Matrox Inc, Montreal,
Quebec, Canada). Total amount of growth factor expression
for each animal was reported as mean area of positive stain
(square millimeters).
Vascular density. TMR-induced angiogenesis was quanti-
fied by measuring vascular density of VEGF- and factor
VIII–stained blood vessels per high-power field around punc-
ture sites. Positively stained vessels were defined as round
structures with a central lumen, which was lined by a thin
layer of endothelium stained positively for VEGF or factor
VIII. Eight measurements were taken for each tissue section
by means of the same sampling method. Results of angio-
genesis for each animal were reported as mean number of
vessels per high-power field.
Statistical analysis. All numeric data were reported as
mean ± 1 standard deviation where applicable. Data analyses
with the Student t test were performed with SPSS 7.5.2 for
Windows software (SPSS Inc, Chicago, Ill).
Results
Mortality. Two deaths occurred in group II on post-
operative day 2 after TMR. Autopsy showed severe
pulmonary congestion and tissue edema with no evi-
dence of myocardial infarction. The presumed cause of
death was congestive heart failure.
Histology. All animals had complete occlusion of the
left circumflex coronary artery at the time of sample
harvesting. In only 1 of the 15 animals, a small area of
transmural scar was noticed at the 2nd operation before
TMR. This was probably the result of early occlusion
of the ameroid constrictor. In TMR-treated specimens,
the areas of transmural punctures were easily identified
by the presence of numerous fibrous scars on the endo-
cardium.
Under low-power light microscopic examinations,
transmural puncture sites could be identified as central
fibrous tracts surrounded by inflammatory changes. All
channels were completely occluded by fibrosis. One
week after TMR (group I), the fibrous tracts consisted
mainly of fibroblasts and collagen material with occa-
sional small blood vessels. The surrounding area consist-
ed of granulation tissue and damaged myocardium with
infiltrating lymphocytes and macrophages. These were
similar to the typical inflammatory changes during the
normal tissue healing process. Numerous small vascular
structures were also found in the area of tissue inflam-
mation. These vessels were morphologically indistin-
guishable from native myocardial capillaries except for
their endothelium, which was positively stained for
VEGF or factor VIII (Fig 1). Most of these vessels were
smaller than 10 m m in diameter and were believed to be
at various stages of angiogenic development.
Inflammatory changes related to needle punctures
were limited to their immediate vicinity. Each puncture
site was separated from others by normal-looking
myocardium indistinguishable from the control speci-
men under light microscopy.
Four weeks after needle puncture (group II), the trans-
mural channels were completely replaced by fibrous
scar tissue. Significantly less inflammatory cellular
infiltrate was observed in the granulation tissue sur-
rounding needle tracts. Compared with group I, fewer
vessels with positively stained endothelium were found
in group II. However, the remaining vessels were more
mature looking and had a somewhat larger diameter.
Angiogenic growth factor expression. Parallel
comparison revealed that different angiogenic growth
factors had distinct stain patterns (Fig 2). In samples
taken 1 week after needle puncture (group I), several
cell types stained positively for VEGF, including
endothelial cells, macrophages, fibroblasts, and
myocytes. In general, positive stains were limited to
areas adjacent to the puncture sites. Endothelium and
macrophages gave the most intense stains but repre-
sented only a small portion of the total area as mea-
sured by computer-assisted morphometry. On the other
hand, myocytes and fibroblasts produced a more dif-
fused staining pattern and represented most of our mea-
surements for VEGF expression (0.47 ± 0.03 mm2 vs
0.05 ± 0.05 mm2; P < .001; Fig 3, A). Staining was
minimal in areas away from puncture sites, and mea-
surements from these areas were not significantly high-
er than the baseline.
Four weeks after TMR (group II), there was less
VEGF staining in the endothelial cells and macro-
phages. However, positive stain from myocytes and
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fibroblasts persisted, and the overall level as measured
by morphometric analysis was still significantly higher
than that of control specimens (0.34 ± 0.06 mm2 vs
0.05 ± 0.05 mm2; P = .003; Fig 3, A).
Basic FGF stained much differently from VEGF. One
week after TMR (group I), there was strong staining of
fibroblasts along the needle tracts by anti-bFGF anti-
sera (0.67 ± 0.14 mm2 vs 0.03 ± 0.03 mm2; P < 0.001;
Fig 3, B). Very little stain was found in other cell types.
The level of bFGF stain dropped to baseline at 4 weeks
(group II, 0.06 ± 0.02 mm2 vs 0.03 ± 0.03 mm2; P =
.135; Fig 3, B).
TGF-b stain followed a pattern similar to that of
VEGF 1 week after TMR (group I), that is, endothelial
cells, macrophages, myocytes, and fibroblasts. Again,
most of the morphometric measurement was from
myocytes and fibroblasts, which gave a more diffuse
stain pattern (1.40 ± 0.18 mm2 vs 0.09 ± 0.06 mm2; P
< .001; Fig 3, C). At 4 weeks (group II), the level of
stain had decreased considerably but was still signifi-
cantly higher than that of the baseline (0.28 ± 0.09 mm2
vs 0.09 ± 0.06 mm2; P = .042; Fig 3, C).
Angiogenesis. One week after needle puncture
(group I), the number of vascular structures in the
vicinity of needle punctures had increased significant-
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Fig 1. Representative images from TMR-treated area (200· )
illustrating increased number of small vessels with endothe-
lium stained for VEGF (A) or factor VIII (B).
Fig 2. Representative digitized image of TMR-treated tissue
section (200· ) stained for VEGF (A), bFGF (B), and TGF-b (C).
ly. This increase in vascular density was found by both
VEGF staining (8.1 ± 0.6 vs 1.1 ± 0.5; P < .001) and
factor VIII staining (5.1 ± 2.7 vs 0.4 ± 0.3; P = .018).
These vessels were mostly between 2 and 10 m m in
diameter and were believed to be at various stages of
angiogenic development (Fig 1).
The number of VEGF-stained vessels dropped to
baseline at 4 weeks (1.9 ± 0.5 vs 1.1 ± 0.5; P = .107),
and the number of factor VIII–stained vessels was
lower but still significantly higher than that of the con-
trol specimens (2.3 ± 0.4 vs 0.4 ± 0.3; P = .004).
Comparison of vascular densities is shown in Fig 4.
Discussion
Since it was first introduced by Mirhoseini and
Cayton,7 all clinical studies of TMR have used laser
devices. This is not surprising, since the laser industry
has been instrumental in providing technical and finan-
cial support for this procedure from the beginning.
Although no evidence has been produced to substanti-
ate the proposed benefit of laser, laser TMR remains
the only procedure accepted in clinical practice.
Without a clear understanding of its mechanism, this
situation will likely remain unchanged despite the tech-
nical complexity and significant cost associated with
laser TMR.
Debates over the basic mechanism of TMR have a
history almost as long as that of the procedure itself.
The initial “open-channel” hypothesis based on a rep-
tilian-style transmural perfusion is no longer supported
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Fig 3. Comparison of angiogenic growth factor expression in
all treatment groups. Growth factor expression is measured
by mean area of VEGF stain (mm2) per high-power field.
Error bars represent 1 standard deviation. P values are com-






Fig 4. Comparison of vascular densities. Mean number of
vessels per high-power field is shown in the Y-axis. Error
bars represent 1 standard deviation. P values are comparisons
against group III. A, VEGF; B, factor VIII.
by the currently available research data. Not only is
there a lack of evidence indicating the existence of
patent channels beyond the immediate postoperative
period, but the potential amount of blood flow through
these channels is also insignificant because of physio-
logic limitations.8,9 More recently, several other
hypotheses have been proposed in an effort to explain
the apparent effectiveness of TMR in reducing angina
symptoms, among these, angiogenesis.
TMR-induced angiogenesis is based on the observa-
tion that significant inflammatory reaction is consis-
tently present in the vicinity of myocardial punc-
tures.10-13 Angiogenesis and neovascularization play a
central role during the initial phases of wound heal-
ing.14 This angiogenic response is stimulated by vari-
ous growth factors released as a result of tissue injury
and inflammatory cellular infiltration. The end result is
seen as increased vascular density in the injured area.
Central to this angiogenic hypothesis is that the release
of angiogenic growth factors is a nonspecific response
to tissue injury, which can be created by a variety of
methods. Although laser was initially used to improve
long-term channel patency, perhaps its true value is
simply being a glamorous way to incite myocardial
injury. In fact, a recent study of TMR by radio frequen-
cy ablation in a porcine model of chronic ischemia also
showed increased angiogenesis. Simple needle punc-
tures of myocardium have also been shown to induce
an angiogenic response in an acute ischemic rat
model.1 More recently, we demonstrated that 1 week
after TMR, treatments with both needle and carbon
dioxide laser punctures resulted in a similar increase in
the expression of VEGF and tissue vascular density.4
Armed with these encouraging preliminary results, we
took a closer look at mechanical needle TMR as a
potential alternative to laser TMR.
Several observations from our study are consistent
with the hypothesis of injury-induced angiogenic
response. One week after a mechanical TMR proce-
dure, an intense inflammatory reaction surrounded the
myocardial puncture sites, which is characteristic of a
wound healing process. The intensity of tissue inflam-
mation was markedly reduced by 4 weeks after the
operation as the healing process has moved from the
inflammatory toward the proliferating phase. As
expected, different growth factors had distinct stain pat-
terns, which is a reflection of their intrinsic protein syn-
theses and ligand bindings. All 3 growth factors had a
significantly elevated level of expression at 1 week. At
4 weeks, the levels of VEGF and TGF-b decreased sig-
nificantly as a result of diminished inflammatory cellu-
lar infiltrates and less staining of myocytes and fibro-
blasts. However, their levels remained elevated when
compared with those of control specimens. On the
other hand, bFGF stain was mainly limited to the
fibroblasts along needle puncture sites, and its level
returned to baseline with maturing of the scar tissue.
Increased angiogenic growth factor expression was
limited to the region of myocardial punctures. In sam-
ples taken from the interventricular septum of group I
and group II animals, the levels of angiogenic factors
and vascular densities were similar to those of group III
animals.
VEGF is a potent direct stimulant of neovasculariza-
tion and vessel proliferation with receptors on the
endothelial cells. Significantly higher number of devel-
oping vessels with VEGF-stained endothelium were
found at 1 week. We postulate that these were newly
formed vessels stimulated by locally secreted VEGF.
When sections from the 4-week group were analyzed,
the number of VEGF-stained vessels had decreased to
that of the baseline. However, this was mostly due to
decreased VEGF binding to its endothelial receptors
rather than disappearance of newly formed vessels.
Staining with factor VIII confirmed that vascular den-
sity was reduced but still significantly higher than that
of control samples. Although the level of angiogenic
growth factors will gradually return to baseline after
mechanical TMR, some of the newly formed vessels
will likely remain open in the presence of tissue
ischemia.
TMR angiogenesis occurs at the expense of myocardial
injury. It is important to take into consideration the issue
of TMR “efficiency,” which could be defined as the level
of angiogenesis at a given amount of muscle destruction.
Whether mechanical trauma by needle punctures or laser
thermal injury is more efficient in creating angiogenesis
remains to be clarified by future studies.
In summary, our study demonstrated that mechanical
needle TMR is effective in stimulating intrinsic expres-
sion of several different angiogenic growth factors, and
these findings were fundamentally indistinguishable
from other studies of TMR using laser devices. In view
of this and the significant cost implication, we believe
that it is justifiable and perhaps desirable to include a
mechanical needle TMR arm for comparison with laser
TMR in future clinical trials.
Two questions remain to be answered by this study:
What is the fate of mechanical TMR–induced vessels
beyond 1 month? What is the functional significance of
these vessels? Future studies with longer follow-up
time, as well as functional and perfusion studies of
mechanical TMR–treated myocardium, would help to
answer these questions.
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Discussion
Dr Ernst Wolner (Vienna, Austria). In 1969 I published an
experimental study very similar to yours, with ameroid con-
strictors, but I did not use this puncture. That was the time of
the Vineberg operation. I used strips from the jugular vein
and a curved needle, and I positioned 7 to 8 of these strips on
the left anterior wall, from the outside to the inside of the cav-
ity and back to the outside. At that time we did not have
growth factor, but we did find some new vessels. 
Using xenon 133, we also made some overall measure-
ments of blood flow on the anterior wall of the left ventricle.
We found an increase in the overall blood supply or blood
perfusion of the anterior wall. Thus these old experiments are
in complete accordance with your data, indicating that it
seems to be enough to create an injury to get some changes
and not to use this very expensive laser. 
Dr Chu. Thank you, Dr Wolner. 
Dr Thomas M. Egan (Chapel Hill, NC). That was a very
nice presentation. I wonder about the accuracy of using
immunohistochemical staining for your outcome measures.
Specifically, how did you deal with background expression?
Have you made an attempt to measure messenger RNA
instead of relying on expression? 
Dr Chu. These are very good points. First of all, to exam-
ine the presence of background angiographic expression, we
stained tissue sections not only from sham-operated animals,
which is our control group, but also from unpunctured areas
in our treatment groups. Although these results were not
shown here, we found that the levels of immunostaining from
unpunctured areas were consistently low and similar to those
of our control group. It seems that background expression is
not a big problem.
Messenger RNA level was not measured in this particular
study.
Dr Beat H. Walpoth (Bern, Switzerland). It seems that
you did not do TMR and needle puncture in the same animal
but rather did a historical comparison. You did not present
results comparing the 2 techniques. You just showed that nee-
dle puncture will induce growth factors. I think this point is
worth mentioning, although it has been noted before.
An interesting question, however, is to know whether laser-
induced injury, yielding a stronger and bigger injury, will
induce quantitatively more growth factors. Can you comment? 
Dr Chu. Absolutely. In fact, this study was an extension of
our preliminary experiments, which were presented before
the Society for Thoracic Surgeons meeting in San Antonio. In
that study, we directly compared the effect of needle punc-
tures versus carbon dioxide laser TMR. I agree that individ-
ual laser puncture causes much more tissue damage and
therefore more angiogenic factor expression per puncture.
However, we also showed that such difference was only
quantitative and could be fully compensated by simply
increasing the number of needle punctures.
There is a balance between tissue damage and angiogenic
response, and I cannot tell you whether needle or laser is
more efficient. However, the bottom line is that the same
level of angiogenesis can be achieved using simple needle
punctures.
Dr Jakob Vinten-Johansen (Atlanta, Ga). Is there a
cause-and-effect relationship between the local expression of
angiogenic factors and the actual capillary density that is
observed?
Dr Chu. We definitely found that tissue capillary densities
parallel the levels of various angiogenic factors. In addition,
we found an increased number of vessels in needle-treated
areas with VEGF-stained endothelium. We think these could
be locally produced protein products binding to endothelial
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receptors. Yes, we believe there is a cause-and-effect
relationship. 
Dr Paul Kurlansky (Miami Beach, Fla). Dr Chu, I am fol-
lowing your work with interest. I saw your presentation at the
Society for Thoracic Surgeons meeting. My question regard-
ing needle puncture versus laser TMR is as follows: Have you
done any studies on the time course and the quality of the
effect in addition to the work you have shown us on the quan-
tity of the effect? In other words, is there a similar time course
as regards neovascularization and VEGF expression, and are
there other growth factors that are expressed differentially
with one technique versus the other? 
Dr Chu. Thank you very much. This study was meant to
further characterize angiogenesis of mechanical needle TMR
only. We included 2 animal groups at 1 and 4 weeks postop-
eratively for the purpose of time-course study. We also looked
at several different angiogenic factors, as well as including
factor VIII for measuring vascular density. Indeed, the pat-
terns of expression and the time course of different angio-
genic factors were quite distinct from one another.
I think an important question here is whether the increased
vascular density has any functional significance. This will be
answered by myocardial perfusion studies currently in
progress in our laboratory.
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